January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Gustavo Viani: Breaking Barriers in Global Oncology
Jan 19, 2025, 14:19

Gustavo Viani: Breaking Barriers in Global Oncology

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, University of Sao Paulo, shared a post on LinkedIn:

“Breaking Barriers in Global Oncology.

We proudly introduce the Linear Accelerator Shortage Index (LSI)—a groundbreaking tool designed to bring hope and healing to regions where radiotherapy is most needed.

Methods

-Cross-sectional, population-based approach, we developed the Linear Accelerator Shortage Index (LSI) to analyze global radiotherapy access.
-This tool combines population data, cancer incidence, and existing capacity to identify regions most in need and provide personalized recommendations for LINAC allocation.

Why This Study Matters?

  • Fighting Inequality: Pinpoints the hardest-hit regions, particularly underserved low- and middle-income countries.
  •  Personalised Solutions: Offers actionable, data-driven recommendations for policymakers.
  • Saving Lives: Expanding radiotherapy access could save millions—patients, families, and futures.”

Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study.

Authors: Fabio Y Moraes, Andre G Gouveia, Vanessa Freitas Bratti, Edward C Dee, Juliana Fernandes Pavoni, Laura M Carson, Cecília Félix Penido Mendes de Sousa, Richard Sullivan, Gustavo Nader Marta, Wilma M Hopman, Christopher M Booth, Ajay Aggarwal, Ahmedin Jemal, Timothy P Hanna, Brooke E Wilson, Gustavo Arruda Viani.

Gustavo Viani

Gustavo Viani, MD is an Associate Professor in the Department of Medical Imaging, Hematology, and Oncology at Hospital das Clínicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP). Dr. Viani’s research focuses on radiation oncology, with expertise in brachytherapy, stereotactic radiosurgery, dose fractionation, radiation tolerance, and overall oncology practices.